Mirixa Corporation, Reston, VA, USA.
J Am Pharm Assoc (2003). 2009 Nov-Dec;49(6):813-20. doi: 10.1331/JAPhA.2009.09066.
To describe experiences with medication therapy management (MTM) services delivered to benefciaries of Mirixa's health plan clients.
United States during 2007.
Three intervention modalities were offered to provide MTM services: community pharmacy, pharmacist-staffed call centers, and educational mailings. Available data were analyzed to identify any differences among patients receiving any of the three interventions. Patients included in the analysis were those who qualifed for MTM services between April 1, 2007, and June 30, 2007. MTM services were provided for these patients between May 1, 2007, and December 31, 2007.
The MirixaPro platform was created to document the activities associated with the five core elements of an MTM service (medication therapy review, creation of a personal medication record, creation of a medication-related action plan [MAP], intervention and/or referral, and documentation and follow-up). It provides a framework for capturing safety interventions, follow-ups with prescribers, and pharmacist instructions to the patients.
Part D drug costs, use, and generic dispensing ratio in the pre- and post-MTM periods.
21,336 patients received MTM services from a community pharmacist (face to face, 9,140; by phone, 12,196), 3,436 patients received MTM services from a call center pharmacist, and 49,021 patients received an educational mailing. Patients who had a face-to-face session had a decline in mean monthly drug costs of $29 (from $658 to $629), while drug costs decreased by $40 (from $677 to $637) when the community pharmacist provided the services over the telephone. Mean monthly drug costs decreased by $15 (from $676 to $661) for patients receiving MTM services from a call center pharmacist and did not change for patients receiving an educational mailing ($698 in both periods).
Among patients who received MTM services in 2007, drug costs decreased for those who received service from community pharmacists, decreased somewhat for patients who received service from a call center pharmacist, and were unchanged for those who received MTM via mailing. Further studies are needed to assess the effect of various types of MTM interventions on fnancial, clinical, and humanistic outcomes.
描述 Mirixa 健康计划客户的受益人接受药物治疗管理（MTM）服务的经验。
美国，2007 年。
提供了三种干预模式来提供 MTM 服务：社区药房、药剂师人员配备的呼叫中心和教育邮件。对现有数据进行了分析，以确定接受三种干预措施的任何患者之间的差异。分析中包括符合 MTM 服务条件的患者，这些患者在 2007 年 4 月 1 日至 2007 年 6 月 30 日期间有资格获得 MTM 服务。这些患者在 2007 年 5 月 1 日至 2007 年 12 月 31 日期间接受了 MTM 服务。
创建了 MirixaPro 平台来记录与 MTM 服务的五个核心要素（药物治疗审查、建立个人用药记录、建立药物相关行动计划[MAP]、干预和/或转介以及记录和随访）相关的活动。它为捕获安全干预措施、与处方医生的随访以及药剂师向患者的指示提供了一个框架。
预 MTM 和后 MTM 期间的 Part D 药物费用、使用和通用配药比例。
21,336 名患者接受了社区药剂师的 MTM 服务（面对面，9,140；电话，12,196），3,436 名患者接受了呼叫中心药剂师的 MTM 服务，49,021 名患者收到了教育邮件。与接受电话服务的社区药剂师提供服务的患者相比，接受面对面服务的患者每月药物费用下降了 29 美元（从 658 美元降至 629 美元），而社区药剂师提供服务时，药物费用下降了 40 美元（从 677 美元降至 637 美元）。接受呼叫中心药剂师 MTM 服务的患者每月药物费用下降了 15 美元（从 676 美元降至 661 美元），而通过邮件接受 MTM 服务的患者费用没有变化（两个时期均为 698 美元）。
在 2007 年接受 MTM 服务的患者中，接受社区药剂师服务的患者药物费用下降，接受呼叫中心药剂师服务的患者药物费用略有下降，通过邮件接受 MTM 服务的患者药物费用不变。需要进一步研究以评估各种类型的 MTM 干预措施对财务、临床和人性化结果的影响。
